According to the World Health Organization (WHO), GLP-1 therapies short for glucagon-like peptide-1 receptor agonists work by mimicking a natural hormone that: Regulates appetite Slows stomach emptying Improves blood sugar control The WHO says GLP-1s were originally developed to treat type 2 diabetes
Yang F, Cao X, Yang T, Feng W, Tong Q, Liu K, Wu L, Lin H, Fan Q
According to CDC data, non-Hispanic Black and Hispanic adults have the highest prevalence of obesity in the U.S
Retatrutides effects on blood sugar, inflammation, and shrinking waists might all work together to support heart health, especially in obese people who are generally more prone to cardiovascular issues
Providing incentives for local businesses to offer healthier food options